Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Two essential Thioredoxins mediate apicoplast biogenesis, protein import, and gene expression in Toxoplasma gondii.

Biddau M, Bouchut A, Major J, Saveria T, Tottey J, Oka O, van-Lith M, Jennings KE, Ovciarikova J, DeRocher A, Striepen B, Waller RF, Parsons M, Sheiner L.

PLoS Pathog. 2018 Feb 22;14(2):e1006836. doi: 10.1371/journal.ppat.1006836. eCollection 2018 Feb.

2.

Inhibition of IRE1α-mediated XBP1 mRNA cleavage by XBP1 reveals a novel regulatory process during the unfolded protein response.

Chalmers F, van Lith M, Sweeney B, Cain K, Bulleid NJ.

Wellcome Open Res. 2017 Oct 9;2:36. doi: 10.12688/wellcomeopenres.11764.2. eCollection 2017.

3.

Cytosolic thioredoxin reductase 1 is required for correct disulfide formation in the ER.

Poet GJ, Oka OB, van Lith M, Cao Z, Robinson PJ, Pringle MA, Arnér ES, Bulleid NJ.

EMBO J. 2017 Mar 1;36(5):693-702. doi: 10.15252/embj.201695336. Epub 2017 Jan 16.

4.

The membrane topology of vitamin K epoxide reductase is conserved between human isoforms and the bacterial enzyme.

Cao Z, van Lith M, Mitchell LJ, Pringle MA, Inaba K, Bulleid NJ.

Biochem J. 2016 Apr 1;473(7):851-8. doi: 10.1042/BJ20151223. Epub 2016 Jan 15.

PMID:
26772871
5.

Redox regulation in the endoplasmic reticulum.

Bulleid NJ, van Lith M.

Biochem Soc Trans. 2014 Aug;42(4):905-8. doi: 10.1042/BST20140065. Review.

PMID:
25109977
6.

Ero1-PDI interactions, the response to redox flux and the implications for disulfide bond formation in the mammalian endoplasmic reticulum.

Benham AM, van Lith M, Sitia R, Braakman I.

Philos Trans R Soc Lond B Biol Sci. 2013 Mar 25;368(1617):20110403. doi: 10.1098/rstb.2011.0403. Print 2013 May 5.

7.

Real-time monitoring of redox changes in the mammalian endoplasmic reticulum.

van Lith M, Tiwari S, Pediani J, Milligan G, Bulleid NJ.

J Cell Sci. 2011 Jul 15;124(Pt 14):2349-56. doi: 10.1242/jcs.085530. Epub 2011 Jun 21.

8.

HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.

van Lith M, McEwen-Smith RM, Benham AM.

J Biol Chem. 2010 Dec 24;285(52):40800-8. doi: 10.1074/jbc.M110.148155. Epub 2010 Oct 19.

9.

A developmentally regulated chaperone complex for the endoplasmic reticulum of male haploid germ cells.

van Lith M, Karala AR, Bown D, Gatehouse JA, Ruddock LW, Saunders PT, Benham AM.

Mol Biol Cell. 2007 Aug;18(8):2795-804. Epub 2007 May 16.

10.

Activation of the unfolded protein response and alternative splicing of ATF6alpha in HLA-B27 positive lymphocytes.

Lemin AJ, Saleki K, van Lith M, Benham AM.

FEBS Lett. 2007 May 1;581(9):1819-24. Epub 2007 Apr 4.

11.

The DMalpha and DMbeta chain cooperate in the oxidation and folding of HLA-DM.

van Lith M, Benham AM.

J Immunol. 2006 Oct 15;177(8):5430-9.

12.

Mutations in the FAD binding domain cause stress-induced misoxidation of the endoplasmic reticulum oxidoreductase Ero1beta.

Dias-Gunasekara S, van Lith M, Williams JA, Kataky R, Benham AM.

J Biol Chem. 2006 Sep 1;281(35):25018-25. Epub 2006 Jul 5.

13.

Tissue-specific expression and dimerization of the endoplasmic reticulum oxidoreductase Ero1beta.

Dias-Gunasekara S, Gubbens J, van Lith M, Dunne C, Williams JA, Kataky R, Scoones D, Lapthorn A, Bulleid NJ, Benham AM.

J Biol Chem. 2005 Sep 23;280(38):33066-75. Epub 2005 Jul 12.

14.

Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape.

Zwart W, Griekspoor A, Kuijl C, Marsman M, van Rheenen J, Janssen H, Calafat J, van Ham M, Janssen L, van Lith M, Jalink K, Neefjes J.

Immunity. 2005 Feb;22(2):221-33.

15.
16.

Cloning and initial characterization of the Arabidopsis thaliana endoplasmic reticulum oxidoreductins.

Dixon DP, Van Lith M, Edwards R, Benham A.

Antioxid Redox Signal. 2003 Aug;5(4):389-96.

PMID:
13678526
17.

Stable expression of MHC class I heavy chain/HLA-DO complexes at the plasma membrane.

van Lith M, van Ham M, Neefjes J.

Eur J Immunol. 2003 May;33(5):1145-51.

18.

Novel polymorphisms in HLA-DOA and HLA-DOB in B-cell malignancies.

van Lith M, van Ham M, Neefjes J.

Immunogenetics. 2002 Nov;54(8):591-5. Epub 2002 Oct 9.

PMID:
12439622
19.

Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body.

van Lith M, van Ham M, Griekspoor A, Tjin E, Verwoerd D, Calafat J, Janssen H, Reits E, Pastoors L, Neefjes J.

J Immunol. 2001 Jul 15;167(2):884-92.

20.

What to do with HLA-DO?

van Ham M, van Lith M, Griekspoor A, Neefjes J.

Immunogenetics. 2000 Aug;51(10):765-70. Review.

PMID:
10970090
21.

Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO.

van Ham M, van Lith M, Lillemeier B, Tjin E, Grüneberg U, Rahman D, Pastoors L, van Meijgaarden K, Roucard C, Trowsdale J, Ottenhoff T, Pappin D, Neefjes J.

J Exp Med. 2000 Apr 3;191(7):1127-36.

22.

Organ-specific pancreatic tumor growth properties and tumor immunity.

Morikane K, Tempero RM, Sivinski CL, Nomoto M, Van Lith ML, Muto T, Hollingsworth MA.

Cancer Immunol Immunother. 1999 Jan;47(5):287-96.

PMID:
10022473
23.

Prosthetic programme after above-knee amputation in children with sarcomata.

Cole WG, Klein RW, van Lith M, Jarvis R.

J Bone Joint Surg Br. 1982;64(5):586-9.

PMID:
6958675

Supplemental Content

Loading ...
Support Center